8-Methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-carbaldehyde

Catalog No. :
ACMCSF029
CAS No. :
711022-06-9
Molecular Formula :
C10H9NO3
Molecular Weight :
191.19

IUPAC Name:8-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-carbaldehyde

8-Methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$199.00Login to see priceInquiryInquiry
250mg95%$319.00Login to see priceInquiryInquiry
1g95%$799.00Login to see priceInquiryInquiry
5g95%$2399.00Login to see priceInquiryInquiry
10g95%$3999.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-Methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-carbaldehyde
IUPAC Name8-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-carbaldehyde
MDL No.MFCD09909922
Molecular FormulaC10H9NO3
Molecular Weight191.19
SMILESO=CC1=CC(C)=C(C(N2)=C1)OCC2=O
InChI KeyYLEDGIQUMYQYGG-UHFFFAOYSA-N
Synonym8-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-carbaldehyde;2H-1,4-Benzoxazine-6-carboxaldehyde, 3,4-dihydro-8-methyl-3-oxo-
CAS No.711022-06-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACMCSF029 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMCSF029 route product structure diagram
    ACMCSF029711022-06-9
Inquiry

2. ACMCSF029 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHOYD298 route compound structure diagram
    ACHOYD298121564-97-4 In Stock
  4. Then
  5. ACMCSF029 route product structure diagram
    ACMCSF029711022-06-9
Inquiry

Comments (0)